120 related articles for article (PubMed ID: 12643927)
1. Discovery of a potent and selective agonist of the prostaglandin EP4 receptor.
Billot X; Chateauneuf A; Chauret N; Denis D; Greig G; Mathieu MC; Metters KM; Slipetz DM; Young RN
Bioorg Med Chem Lett; 2003 Mar; 13(6):1129-32. PubMed ID: 12643927
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel prostaglandin analogs of PGE2 as potent and selective EP2 and EP4 receptor agonists.
Xiao Y; Araldi GL; Zhao Z; Brugger N; Karra S; Fischer D; Palmer E
Bioorg Med Chem Lett; 2007 Aug; 17(15):4323-7. PubMed ID: 17531488
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of novel pyrazolidinone analogs of PGE2 as EP2 and EP4 receptors agonists.
Zhao Z; Araldi GL; Xiao Y; Reddy AP; Liao Y; Karra S; Brugger N; Fischer D; Palmer E
Bioorg Med Chem Lett; 2007 Dec; 17(23):6572-5. PubMed ID: 17931866
[TBL] [Abstract][Full Text] [Related]
4. EP4 and EP2 receptor subtypes involved in colonic secretion in rat.
Mosa AS; Hansen MB; Tilotta CM; Bindslev N
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):214-21. PubMed ID: 18684231
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.
Shoji Y; Takahashi M; Kitamura T; Watanabe K; Kawamori T; Maruyama T; Sugimoto Y; Negishi M; Narumiya S; Sugimura T; Wakabayashi K
Gut; 2004 Aug; 53(8):1151-8. PubMed ID: 15247185
[TBL] [Abstract][Full Text] [Related]
7. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.
Davis TL; Sharif NA
Br J Pharmacol; 2000 Aug; 130(8):1919-26. PubMed ID: 10952683
[TBL] [Abstract][Full Text] [Related]
9. The vasopressin type 2 receptor and prostaglandin receptors EP2 and EP4 can increase aquaporin-2 plasma membrane targeting through a cAMP-independent pathway.
Olesen ET; Moeller HB; Assentoft M; MacAulay N; Fenton RA
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F935-F944. PubMed ID: 27558562
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts.
Shin JM; Park IH; Moon YM; Hong SM; Cho JS; Um JY; Lee HM
Am J Rhinol Allergy; 2014; 28(3):e120-4. PubMed ID: 24980222
[TBL] [Abstract][Full Text] [Related]
11. Generation of ROS by CAY10598 leads to inactivation of STAT3 signaling and induction of apoptosis in human colon cancer HCT116 cells.
Chae IG; Kim DH; Kundu J; Jeong CH; Kundu JK; Chun KS
Free Radic Res; 2014 Nov; 48(11):1311-21. PubMed ID: 25096910
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor.
Belley A; Chadee K
Gastroenterology; 1999 Dec; 117(6):1352-62. PubMed ID: 10579976
[TBL] [Abstract][Full Text] [Related]
13. Role of EP3 and EP4 prostaglandin receptors in reorganization of the cytoskeleton in mature human osteoclasts.
Sarrazin P; Hackett JA; Fortier I; Gallant MA; de Brum-Fernandes A
J Rheumatol; 2004 Aug; 31(8):1598-606. PubMed ID: 15290741
[TBL] [Abstract][Full Text] [Related]
14. Distinction between relaxations induced via prostanoid EP(4) and IP(1) receptors in pig and rabbit blood vessels.
Jones RL; Chan K
Br J Pharmacol; 2001 Sep; 134(2):313-24. PubMed ID: 11564649
[TBL] [Abstract][Full Text] [Related]
15. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity.
Scott G; Leopardi S; Printup S; Malhi N; Seiberg M; Lapoint R
J Invest Dermatol; 2004 May; 122(5):1214-24. PubMed ID: 15140225
[TBL] [Abstract][Full Text] [Related]
16. Lactams as EP4 prostanoid receptor subtype selective agonists. Part 1: 2-Pyrrolidinones-stereochemical and lower side-chain optimization.
Elworthy TR; Kertesz DJ; Kim W; Roepel MG; Quattrocchio-Setti L; Smith DB; Tracy JL; Chow A; Li F; Brill ER; Lach LK; McGee D; Yang DS; Chiou SS
Bioorg Med Chem Lett; 2004 Apr; 14(7):1655-9. PubMed ID: 15026044
[TBL] [Abstract][Full Text] [Related]
17. Suppression of acute rejection by administration of prostaglandin E2 receptor subtype 4 agonist in rat organ transplantation models.
Okamoto T; Okamoto S; Fujimoto Y; Tabata Y; Uemoto S
J Surg Res; 2013 Aug; 183(2):852-9. PubMed ID: 23478083
[TBL] [Abstract][Full Text] [Related]
18. E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype.
Clarke DL; Giembycz MA; Patel HJ; Belvisi MG
Br J Pharmacol; 2004 Feb; 141(4):600-9. PubMed ID: 14744812
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression, cytokine production, and lymphocyte proliferation in human peripheral blood mononuclear cells.
Takahashi HK; Liu K; Wake H; Mori S; Zhang J; Liu R; Yoshino T; Nishibori M
J Pharmacol Exp Ther; 2009 Nov; 331(2):656-70. PubMed ID: 19700629
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes.
Harizi H; Grosset C; Gualde N
J Leukoc Biol; 2003 Jun; 73(6):756-63. PubMed ID: 12773508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
